University of Siena
Alessandro Pini is Associate Professor of Biochemistry at the University of Siena, Italy. He has a degree in Biology, a PhD in Biotechnology, and a postgraduate degree in Clinical Biochemistry. He was visiting researcher at the Centre of Protein Engineering, MRC, Cambridge, UK, and at the Swiss Federal Institute for Research (ETH), Zurich, Switzerland. He is founder and president of the company SetLance, based in Siena. SetLance has a special focus in the identification and early development of peptide-based drugs. Currently SetLance is developing a peptide-antibiotic for the cure of the most important infections due to Gram-Negative bacteria. He is author of dozens of publications and inventor in 12 patents regarding antibodies and peptides and their applications.